COVID-19 testing
The study indicated that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection.
The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.
Researchers from SMART’s AMR IRG, NTU and MIT are working together to develop a rapid serological test and a rapid diagnostic test (RDT), based on protein detection.
Professor Wang Linfa, Director of the Duke-NUS’ Emerging Infectious Diseases programme, and team conceived this research and invented the cPass diagnostic test.
Following a virtual consultation, both companies are supplying Rutgers Clinical Genomics Laboratory's saliva-based molecular test to consumers at $150 per kit.
"Virtual Office for Doctors" had been built to ensure secure remote consultations.
Users will now be able to collect a sample at home and send it to the lab in a sealed package.
Also - wearable devices, contact tracing apps and remote consultations in this week's MobiHealthNews Roundup.
The startup, which specializes in a range of at-home testing kits, so far only offers a COVID-19 testing product for point-of-care providers.
Also: HHS awards $20 million in telehealth access, infrastructure funds; Lumi launches online service.